ADMA
ADMA Biologics Surges 10% on a Profit Beat, but Can One Star Product Carry a Company With a Shrinking Second Act?
Shares shifted sharply higher as ADMA Biologics jumped 10% to $10.19 on August 7, two days after its second-quarter earnings revealed a company being remade by...